Leadership Supporting GenBio’s Scientific and Corporate Direction.

Giles Tilley is the Founder and Chief Executive Officer of GenBio Inc., where he provides the strategic vision guiding the company's mission to advance novel biotechnology solutions inspired by nature. With more than three decades of experience spanning natural health products, research commercialization, and international business development, Mr. Tilley has built a career focused on identifying scientifically promising natural compounds and translating them into commercially viable technologies.

Throughout his career, he has cultivated collaborations with academic researchers, scientific institutions, government organizations, and industry partners to advance multidisciplinary research programs and intellectual property development. His leadership emphasizes rigorous scientific evaluation, responsible stewardship of innovation, and the development of strategic partnerships capable of accelerating therapeutic discovery and commercialization.

As Chief Executive Officer, Mr. Tilley oversees GenBio's corporate strategy, intellectual property initiatives, scientific collaborations, and long-term business development activities. He is committed to building an organization that combines scientific excellence with disciplined corporate governance while fostering an environment where innovation, collaboration, and strategic execution support the advancement of biotechnology solutions addressing significant unmet medical needs.

His leadership continues to shape GenBio's evolution as a research-driven biotechnology company focused on creating long-term value through scientific innovation and strategic global partnerships.

Professor Lindsay Brown serves as Chief Scientific Officer of GenBio Inc., providing scientific leadership across the Company's research platform and development programs. An internationally respected pharmacologist and academic researcher, Professor Brown has built an extensive career dedicated to cardiovascular physiology, metabolic disease, inflammation, and translational biomedical research.

His research has contributed to a broad body of peer-reviewed scientific literature and has advanced understanding of natural bioactive compounds and their potential therapeutic applications. Throughout his academic career, Professor Brown has led multidisciplinary research initiatives, supervised postgraduate researchers, and collaborated with scientific institutions around the world in advancing evidence-based biomedical discovery.

At GenBio, Professor Brown guides scientific strategy, research evaluation, experimental design, and development planning while helping ensure that the Company's programs are grounded in rigorous scientific methodology and reproducible research practices. His expertise supports the translation of promising scientific discoveries into development opportunities while maintaining a strong commitment to research integrity and scientific excellence.

Professor Brown's leadership reinforces GenBio's commitment to advancing biotechnology through disciplined science, collaborative research, and a long-term focus on therapeutic innovation.

Todd D. Sonoga serves as Director and Chief Marketing Officer of GenBio Inc., where he leads the Company's corporate communications, strategic marketing, business development, and partnership initiatives. With more than two decades of experience in corporate strategy, investor communications, branding, and capital markets, Mr. Sonoga has developed expertise in positioning emerging growth companies for strategic expansion and long-term value creation.

His career has focused on translating complex scientific and technical concepts into clear, compelling communications for investors, strategic partners, and industry stakeholders. At GenBio, he works closely with executive leadership to strengthen the Company's corporate identity, cultivate pharmaceutical partnerships, support commercialization planning, and communicate the value of GenBio's biotechnology platform to global audiences.

Mr. Sonoga also oversees strategic outreach, corporate development initiatives, and engagement with prospective collaborators while helping align scientific innovation with commercial opportunities. His leadership supports GenBio's objective of building lasting relationships across the biotechnology and life sciences sectors through transparent communication, disciplined strategy, and a commitment to professional excellence.

His work continues to support GenBio's growth as it expands its research platform, strategic partnerships, and international presence within the biotechnology industry.